-
Nippon India Pharma Fund - Growth
Equity healthcare
Overview ( as on 05/06/26 )
NAV
₹533.74
Last change
₹2.82 +0.01%
Fund Size (AUM)
8365.40 Cr
Performance
12.65% (5Y)
Fund Details
Nippon India Pharma Fund - Growth
as of 05/06/26
AUM
8365.40 Cr
Expense Ratio
1.52 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01968
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund - Growth | 4.96% | 21.78% | 12.65% |
| BSE Healthcare TR INR | 9.86% | 25.5% | 13.79% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.85% |
Lupin Ltd |
7.95% |
Dr Reddy's Laboratories Ltd |
7.04% |
Divi's Laboratories Ltd |
6.61% |
Cipla Ltd |
5.47% |
Apollo Hospitals Enterprise Ltd |
5.01% |
Medplus Health Services Ltd |
3.78% |
Vijaya Diagnostic Centre Ltd |
3.36% |
Sai Life Sciences Ltd |
3.27% |
Ajanta Pharma Ltd |
3.19% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Fund
Equity healthcare-
Returns
-
15.29% (5Y)
-
-
UTI Healthcare Fund
Equity healthcare-
Returns
-
13.94% (5Y)
-
-
UTI Healthcare IDCW-P Fund
Equity healthcare-
Returns
-
13.94% (5Y)
-
-
UTI Healthcare IDCW-R Fund
Equity healthcare-
Returns
-
13.94% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R Fund
Equity healthcare-
Returns
-
14.64% (5Y)
-
-
SBI Healthcare Opportunities Fund
Equity healthcare-
Returns
-
15.52% (5Y)
-
